ICELANDIC SALMON AS NK 10 risk profile
90 Acute at or past the historical limit
Measured 1 September 2026 from I6X's filed statements. Recomputed nightly.
90 (Acute), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 65 | Stretched | Stable | Drawdown from the 52-week high — 30.3% |
| Operating pressure | 86 | Acute | Worsening | Costs outgrowing revenue — +28.0 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.30x |
| Leverage and coverage | 80 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 97 | Acute | Stable | Operating-margin gap against peers — -32.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for ICELANDIC SALMON AS NK 10